购物车
- 全部删除
- 您的购物车当前为空
Anti-BAFF/TNFSF13B Antibody-PE (9F115) 是一种 PE-conjugated Rabbit 抗体,靶向 BAFF/TNFSF13B。Anti-BAFF/TNFSF13B Antibody-PE (9F115) 可用于 FCM。
Anti-BAFF/TNFSF13B Antibody-PE (9F115) 是一种 PE-conjugated Rabbit 抗体,靶向 BAFF/TNFSF13B。Anti-BAFF/TNFSF13B Antibody-PE (9F115) 可用于 FCM。
产品描述 | Anti-BAFF/TNFSF13B Antibody-PE (9F115) is a PE-conjugated Rabbit antibody targeting BAFF/TNFSF13B. Anti-BAFF/TNFSF13B Antibody-PE (9F115) can be used in FCM. |
Ig Type | Monoclonal Rabbit IgG |
克隆号 | 9F115 |
交叉反应 | Human |
验证活性 | Flow cytometric analysis of Human BAFF(CD257) expression on U937 cells. Cells were stained with PE-conjugated anti-Human BAFF(CD257). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
应用 | FCM |
推荐剂量 | 10 μl/Test, 0.1 mg/ml |
抗体种类 | Monoclonal |
宿主来源 | Rabbit |
构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Human BLyS / TNFSF13B (rh BLyS / TNFSF13B; TMPY-02775; Q9Y275-1; Ala134-Leu285) and conjugated with PE under optimum conditions, the unreacted PE was removed. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
研究背景 | B lymphocyte stimulator (BLyS), also known as TNFSF13B, CD257 and BAFF, is a single-pass type II membrane protein, which belongs to the tumor necrosis factor family. BAFF is abundantly expressed in peripheral blood Leukocytes and is specifically expressed in monocytes and macrophages. BAFF is a cytokine and serves as a ligand for receptors TNFRSF13B (TACI), TNFRSF17 (BCMA), and TNFRSF13C (BAFFR). These receptors are a prominent factor in B cell differentiation, homeostasis, and selection. BLyS levels affect survival signals and selective apoptosis of autoantibody-producing B cells. Thus, it acts as a potent B cell activator and has been shown to play an important role in the proliferation and differentiation of B cells. Overexpression of BLyS in mice can lead to clinical and serological features of systemic lupus erythematosus (SLE) and Sjögren's syndrome (SS). BLyS is an attractive therapeutic target in human rheumatic diseases. The ability of BLyS to regulate both the size and repertoire of the peripheral B cell compartment raises the possibility that BLyS and antagonists thereof may form the basis of a therapeutic trichotomy. As an agonist, BLyS protein may enhance humoral immunity in congenital or acquired immunodeficiencies such as those resulting from viral infection or cancer therapy.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | PE |
其他可选修饰符 | Unconjugated |
可提供抗体种类 | 2 |
免疫原 | Recombinant Human BLyS/TNFSF13B Protein (TMPY-02775) |
抗原种属 | Human |
储存方式 | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
运输方式 | Shipping with blue ice. |
评论内容